STOCKHOLM — Trial results are demonstrating positive findings for a single intravitreal injection gene therapy for patients with neovascular age-related macular degeneration (nAMD) who previously ...
LONDON, August 29 (SPIS MedWire). Vascular endothelial growth factor (VEGF) has been used to increase blood flow to the damaged hearts of patients. The VEGF gene is injected into areas of dead or ...
Long Beach, Calif. – May 2, 2024 – Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients ...
LONG BEACH, Calif. -- A gene therapy for therapeutic angiogenesis showed promise for people with angina who had already exhausted their options for medical therapy and coronary revascularization, ...
At least 20 million Americans ages 40 and older have age-related macular degeneration, and the threat posed by the vision-robbing condition will only grow larger as the population ages. Despite the ...
Vascular endothelial growth factor (VEGF) is pivotal for blood vessel formation and haematopoiesis, but its effect on stem cells has remained unclear. In 27 June Nature, Hans-Peter Gerber and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results